Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
ACCF and AHA Release Guidelines on the Management of Heart Failure
Insights
Manage hypertension and hyperlipidemia to treat early heart failure. For advanced stages, use ACE inhibitors and beta blockers, adding diuretics if fluid retention occurs, to prevent symptomatic heart failure.
Area of Science:
- Cardiology
- Heart Failure Management
Background:
- Stage A heart failure requires addressing modifiable risk factors like hypertension and hyperlipidemia.
- Preventing symptomatic progression in heart failure is crucial.
Purpose of the Study:
- To outline treatment strategies for different stages of heart failure.
- To emphasize the role of specific medications in preventing heart failure progression.
Main Methods:
- Focus on risk factor modification for Stage A.
- Recommend ACE inhibitors and beta blockers for Stage B and C with reduced ejection fraction.
- Incorporate diuretics for Stage C with fluid retention.
Main Results:
- Risk factor management is key for Stage A.
- ACE inhibitors and beta blockers are vital for preventing symptomatic heart failure in Stages B and C.
- Diuretics provide additional benefit for fluid-overloaded Stage C patients.
Conclusions:
- Tailored treatment based on heart failure stage is essential.
- Pharmacological interventions, including ACE inhibitors, beta blockers, and diuretics, play a critical role in managing heart failure.
- Early intervention and risk factor control can prevent symptomatic heart failure.
Abstract:
Treatment of stage A heart failure should focus on reducing modifiable risk factors, including management of hypertension and hyperlipidemia. To prevent symptomatic heart failure, ACE inhibitors and beta blockers should be used in all patients with stage B or C heart failure who have a reduced ejection fraction. Patients with stage C heart failure and fluid retention should be treated with diuretics in addition to ACE inhibitors and beta blockers.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy VI: Nursing Management

